MRSH Marsh & McLennan Companies, Inc.
Marsh & McLennan Companies, Inc., a professional services company, provides advisory services and insurance solutions to clients in the areas of risk, strategy, and people worldwide. The company operates through Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment offers risk management services, such as risk management, insurance broking, insurance program management, risk consulting, analytical modeling, and alternative risk financing services. This segment also offers insurance and reinsurance broking, strategic advisory and actuarial services, and analytics solutions. It serves businesses, public entities, insurance companies, associations, professional services organizations, and private clients. The Consulting segment provides health, wealth and career advice, solutions and products; and specialized management, strategic, economic, and brand consulting services. Marsh & McLennan Companies, Inc. was founded in 1871 and is headquartered in New York, New York.…
Industry Peers
Insurance BrokersKey Statistics
About Marsh & McLennan Companies (NYSE: MRSH)
›
Marsh & McLennan Companies (NYSE: MRSH) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Insurance Brokers industry, part of the Financial Services sector, and reports about 95,000 employees.
The shares were at 206.22 USD on 20 November 2026, up 14.0% over 52 weeks. Its 52-week range is 156.60 USD to 213.99 USD: the price is 3.6% below the high and 31.7% above the low.
At a market capitalisation of 98.06B USD, it trades at 24.7 times trailing earnings and 18.0 times forward earnings. The median trailing P/E of its 17 largest Insurance Brokers peers is 24.1, so MRSH is valued in line with them. It pays a dividend yielding 1.93% (it pays out 44% of its earnings), against a median of 2.46% among the dividend payers in that peer group.
Marsh & McLennan Companies reports return on equity of 27.5%, an operating margin of 24.5% and revenue up 8.1% year over year.
Its debt exceeds its cash by 20.49B USD, a debt-to-equity ratio of 1.42. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 21 analysts cover the stock, with an average rating of Buy; their mean price target of 208.67 USD is 1.2% above the current price. The next earnings report is expected on 28 January 2027.